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Abstract. Myosin II purified from mammalian non-
muscle cells is phosphorylated on the 20-kD light chain
subunit (MLC2o) by the Cat+/calmodulin-dependent
enzyme myosin light chain kinase (MLCK) . The impor-
tance of MLC2o phosphorylation in regulating cell mo-
tility was investigated by introducing either antibodies
to MLCK (MK-Ab) or a Cat+/calmodulin-independent,
constitutively active form of MLCK (MK-) into macro-
phages. The effects of these proteins on cell motility
were then determined using a quantitative chemotaxis
assay. Chemotaxis is significantly diminished in macro-
phages containing MKAb compared to macrophages
containing control antibodies . Moreover, there is an
C
ELLULAR locomotion by mammalian cellsis essential
for embryogenesis, cell-mediated killing (4), and the
formation of metastatic colonies by cancer cells. Cell
motility is a complex process that requires the coordinated
regulation and the interaction of numerous reactions. ATP
hydrolysis by actin and myosin II and myosin II polymeri-
zation/depolymerization are thought to be among the reac-
tions involved in mediating translational motility (2, 23).
In mammalian nonmuscle cells, both ATP hydrolysis (3, 30,
31) and filament formation (1Q 27) by myosin II are regu-
lated by phosphorylation of the 20-kD light chain of myosin
(MLC2o)' by myosin light chain kinase (MLCK) (2) . There-
fore, MLCK and MLC20 phosphorylation are thought to
play critical roles in regulating cell motility.
However, the role of filamentous myosin (myosin II) in cell
motility is unclear. Experiments on the slime mold Dic-
tyostelium discoideum have questioned the importance of
filamentous myosin in cell motility (14, 22) . Dictyostelium
contains two myosins designated myosin I and myosin II
(24) . Myosin I is a single-headed myosin with a short heavy
chain that does not form filaments (24) . Myosin I associates
with lipids (1) and has been localized in the leading edges of
lamellipodia of migrating Dictyostelium ameba(17). Myosin
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ized, constitutively active, myosinlight chainkinase; MK-Ab, affinity-
pun-fled antibodies to myosin light chain kinase; MLCK, myosin light chain
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inverse relationship between the number of cells that
migrate and the amount of MKAb introduced into cells.
Interestingly, there is also an inverse relationship be-
tween the number of cells that migrate and the amount
of MK- introduced into cells. Other experiments dem-
onstrated that MKAb decreased intracellular MLC20
phosphorylation while MK- increased MLC2o phosphor-
ylation. MK- also increased the amount of myosin as-
sociated with the cytoskeleton. These data demonstrate
that the regulation of MLCK is an important aspect of
cell motility and suggest that MLC2o phosphorylation
must be maintained within narrow limits during transla-
tional motility by mammalian cells.
II is similar to mammalian muscle and nonmuscle myosins
in that it has two globular heads, a coiled-coiled tail, and an
ability to form filaments. In contrast to mammalian nonmus-
cle and smooth muscle myosin II, ATP hydrolysis and fila-
ment formation by Dictyostelium myosin II are regulated by
both heavy chain and light chain phosphorylation (24) . In-
terestingly, Diciyostelium in which myosin II heavy chainex-
pression has been genetically manipulated are still capable
of locomotion (14, 22). These data have questioned the im-
portance of myosin II and its regulation by phosphorylation
in cell motility.
On the other hand, experiments on vertebrate cells have
generally supported a role for myosin II and MLCK in cell
motility. The addition ofaffinity-purifiedantibodies to MLCK
(MKAbs) to mouse fibroblasts with permeabilized mem-
branes inhibited lamellipodial retraction (20), while the ad-
dition of trypsinized, constitutively active MLCK (MK-) to
permeabilized chick embryo fibroblasts resulted in MLC20
phosphorylation and lamellipodial contraction (6). Although
lamellipodial retractionis animportant aspectoftranslational
motility, the role ofMLCK in the motile process was not in-
vestigated in these fibroblast preparations because cellswith
permeabilized plasma membranes are incapable of transla-
tion motility and/or chemotaxis.
Therefore, we have investigated the role of myosin II and
its regulation by phosphorylation by MLCK in mediating
mammalian cell motility. In order to do so, MKAb and
MK-, introduced into physiologically responsive macro-
phages with intact plasma membranes, were used to manipu-
late intracellular MLCKactivity. The effects of increasing or
277decreasing MLCK activity on MLC2o phosphorylation and
macrophage chemotaxis were then determined.
Materials andMethods
Proteins
Control antibodies (C-Abs) were purified from normal rabbit serum by
affinity chromatography on a protein A-Sepharose column. MKAbs were
produced and affinity purified as described (11). MK- was prepared by
digesting purified chicken gizzard MLCK with trypsin as previously de-
scribed (21). BSA was also digested withtrypsinat a similar protein/trypsin
ratio (40:1), and used as a control in the MK- experiments. Trypsin was
inactivated by adding a 100-fold excess of soybean trypsin inhibitor to the
BSA and MLCK digests.
Cells
Alveolar macrophages were collected by lung lavage of healthy male 250-
275 g Sprague-Dawley rats. Macrophages were centrifuged at 400 g for
5 min and 2.5 x 106 cells were resuspended in 0.4 ml electroinjection
buffer (140 mM NaCl, 25 mM Hepes, 0.75 mM Na2HP04, pH 7.15) con-
taining the protein to be electroinjected.
Electroinjection
Electroinjection (single discharge) was performed at 0°C and at different
field strengths by changing the voltage setting of a Bio-Rad Laboratories
(Richmond, CA) Gene Pulser (capacitance = 15 AF, interelectrodedistance
of 0.4 cm). The cell suspension was removed from the chamber and in-
cubated for 15 min at 0'C. Themacrophageswererecollected by centrifuga-
tion and resuspended in Gey's balanced salt solution (Grand Island Biologi-
cal Company, Grand Island, NY) containing 1% BSA at N2 x 106
cells/ml. In all experiments, viability was assessed after electroinjection by
adding trypan blue (0.4 %) to an aliquot ofcells and quantifying the percent-
age of cells that excluded dye after 5-15 min at 23°C.
Chemotaxis Assays
Cell motility was quantitated by performing directed chemotaxis assays as
previously described (15). Briefly, 105 cells were loaded into each of the
top chambers of a 48-well microchemotaxis chamber (Neuro Probe, Inc.,
Cabin John, MD). The lower chambers contained endotoxin-activated rat
serum as a chemoattractant (19). The macrophages migrated toward the
chemoattractant passing through a polyvinylpyrrolidone-coated 5-Am pore
size filter. After a 90-min incubationat 37°C, the immigrated macrophages
were scraped off the topside of the filter. The cells that migrated through
the filter and attached to the underside were fixed, stained, and quantified.
Eachcondition wasrun in triplicate and thecells infive oil immersion fields
in each triplicate were counted and averaged to determine the extent of
migration.
Quantitation ofProteinIncorporation
Macrophages electroinjected in the presence of 2.5 mg/ml rhodamine-
labeled BSA were washed three times in Gey's solution. The cells were
resuspended at a concentration of 2 x 106 cells/ml in Gey's solution con-
taining 1% BSA and fluorescence was quantitated using a Perkin-Elmer
model LS-5 fluorescencespectrophotometer (ex/em570/589 run). Fluores-
cence from control cells that were not electroinjected but that were treated
identically to electroinjected cells in every other way were subtracted from
the experimental data. Protein incorporation was calculated based on a
standard curve of fluorescence using known amounts of rhodamine-la-
beled BSA.
Flow Cytometry
The uniformity of protein incorporation was investigated by performing
fluorescence-activated cell sorting. Macrophages were either incubated or
electroinjected (700V/cm) inthe presence of2.5mg/ml fluorescein-labeled
BSA. The cells were washed twice and resuspended in Gey's solution con-
taining 1% BSA. Flowcytometrywasperformedwith a CoulterCorporation
(Hialeah, FL) Epics V flow cytometer with a 256-channel analyzer inter-
faced with multi-parameter data acquisition and display computer system.
5-W argon ionlaser (Coherent, Inc., Palo Alto, CA) emitting at488 nmwas
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operated at 260 mW power. Fluorescence was recorded through a log am-
plifier on a gated population of cells, based upon forward angle and 90°
light-scatter properties that represent the main population of cells, thereby
eliminating any fluorescence readings from cell debris or cell aggregates.
Each analysis was performed on 10,000 cells.
InhibitionofMacrophage MLCKActivitybyMKAb
Macrophages (106 cells) were extracted by freeze/thawing in 0.2 ml of
0.34 M sucrose, 1.0 mM EDTA, 10 mM DTT, 10 mM pyrophosphate, 25
mM Tris, pH 7.5, 2 mg/1 leupeptin and pepstatin, 100 mg/I soybean trypsin
inhibitor, 180 mg/1 phenylmethylsulfonylfluoride, and 1% NP-40. After
centrifugation at 50,000 g for 10 min, the supernatant was made 10 mM
MgATP and fractionated by adding solid (NH4)2SO4. The protein that
precipitated between 35 and 60% saturation, which contained most ofthe
myosin light chain kinase activity, was collected by centrifugation,
resuspended, and dialyzed against 0.3 M NaCl, 1 mM DTT, 1 mM EDTA,
20 mM MOPS, pH 7.2. Approximately 50 leg of the macrophage proteins
were preincubated with 16.5 Kg of MICAb or C-Ab for 5 min at 0°C. The
reaction mixture contained (final concentrations) 0.3 mM CaC12, 0.1 PM
calmodulin, 10 mM MgC12, 10 AM purified chicken gizzard MLC2o, 100
AM .y-32P ATP in a 100-p1 reaction volume. Aliquots from the reaction
mixture were acidprecipitated atdefined timesandprotein-bound cpm were
quantitated. The assays were linear with respect totime. Nonspecific phos-
phorylation, determined by performing kinase assays in the absence of ex-
ogenous MLC2o, was subtracted from the phosphorylation data.
WesternBlotAnalysis
Macrophage (106 cells) and chick embryo fibroblasts (106 cells) were ex-
tracted by freeze/thawing as described above. Approximately 100 jug ofpro-
tein from each cell extract were separated by SDS-PAGE and transferred
to nitrocellulose. The nitrocellulose sheets were then processed using MIC
Ab (4 pg/ml) as theprimary antibody and peroxidase-labeled, goatantirab-
bit antibody as the secondary antibody. The color reaction was developed
using 0.05% 4-chloro-l-naphthol as the substrate.
Determination ofMyosin IIDistribution
Cytoskeletons from macrophages were prepared as previously described
(16). Briefly, an equal volume of ice-cold extraction buffer (2% Triton
X-100, 40 mM sodium pyrophosphate, 20 mM potassium phosphate, 10
mM sodium molybdate, 2 mM N-ethylmaleimide, 2 mM EGTA, pH 7.4)
was added to macrophages suspended in Gey's balanced salt solution. The
insoluble cytoskeletons were immediately isolated by centrifugation at
8730 g for 4 min. The soluble proteins in the supernatant were acetone
precipitated and the pellet was rinsed with a 1:1 dilution of the extraction
buffer and Gey'sbalanced saltsolution, without resuspension, andcollected
by centrifugation. The cytoskeletal proteins and the acetone-precipitated
cytosolic proteins were solubilized by boiling in SDS-sample buffer con-
taining 5 % 2-mercaptoethanol (vol/vol). Approximately 100 Wg ofprotein
from each fraction were separated by SDS-PAGE on a 5-20% gradient slab
gel. The proteins were transferred to 0.2-um pore-size nitrocellulose paper
at 100 mAmp and 4°C for 15 h in 20% methanol, 25 mM Tris-192 MM
glycine, pH 8.3, using a transblot apparatus (Bio-Rad Laboratories). These
conditions permit quantitative transfer ofthe myosin heavy chains without
loss ofthe myosin light chains (see below). Aftertransfer, the nitrocellulose
sheets were processed as Western blots using rabbit antiplatelet myosin II
antibodies and peroxidase-labeled, goat antirabbit antibodies. Antibody
binding was visualized using 4-chloro-l-naphthol as a substrate and aband
corresponding to an M = 204,000, theapparent molecular weight ofmyo-
sin II heavy chain, developed in each lane. The amount of dye in each of
these bands was quantitated by scanning each band with a densitometer
(Joyce-Loebl Ltd., Gateshead, England) in the reflectance mode. The area
defined by thedensitometer tracing, which was a function ofthe dimensions
and the intensity of each band, was taken as a measure of the amount of
myosinIIheavy chain in each fraction. The amountofmyosinII heavy chain
in the cytoskeleton was then expressed as the percent total myosin II heavy
chain in the cytoskeletal and soluble fractions by dividing the area ofthe
cytoskeletal band by the sum of the areas of the cytoskeletal and soluble
fractions.
An important aspect oftheseexperiments is establishing that the myosin
subunits aretransferredquantitativelytothe nitrocellulose sheets. We inves-
tigated the transfer of heavy chains bytransferring the same gel twice using
the conditionsdescribed above. Whenthe blots were developed using rabbit
antibodies to platelet II myosin and peroxidase-labeled secondary antibod-
ies, most ofthe myosin II heavy chain was found on the blot after the first
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Figure L Characterization of the electroinjection procedure. (A)
The relationship between field strength and viability as determined
by trypan blue exclusion (e) and the chemotaxis assay (o) (B) The
relationship between field strength and protein incorporation. (C)
Analysis of electroinjected cells using fluorescence-activated cell
sorting. (A) Macrophages electroinjected with 2.5 mg/ml C-Ab at
different field strengths were recollected by centrifugation and re-
suspended in Gey's balanced salt solution containing 1% BSA at ti2
x 106 cells/ml. Trypan blue (0.4%) was added to an aliquot of
cells and viability was quantified by determining the percentage of
cells that excluded dye. Directed chemotaxis was performed on a
separate aliquot of cells as described in Materials and Methods.
The data points are the mean f SE for three separate experiments
done in triplicate in each category and they represent percent mi-
gration based on nonelectroinjected cells (0 V/cm) as 100% . (B)
Macrophages were electroinjected at different field strengths in the
presence of 2.5 mg/ml rhodamine-labeled BSA (Rh-BSA) . Cells
were washed three times in Gey's solution before quantitating the
fluorescence as described in Materials and Methods. The figure de-
picts the mean t SE of seven separate experiments. Increased in-
corporation of BSA with increasing field strength was significant
(p 4 0.001) as determined by a one-way analysis of variance. (C)
transfer and very little (<5 %) of the heavy chain was detected on the blot
from the second transfer. Transfer ofMLC2o was investigated by separating
two sets ofmolecular weight standards and 50, 100, and 200 ng ofpurified,
32P-labeled MLC2o by SDS-PAGE on a 5-20% acrylamide gradient gel.
One set ofproteins was stained and destained. The other set ofproteins was
transferred tonitrocelluloseasdescribed above, exceptthat two 0.2-umpore
sizenitrocellulose sheets were placed in series onthe anodic side ofthe gel
during thetransfer. Aftertransfer, the regions of the stained gel and the two
nitrocellulose sheets containing MLC2o were excised and the radioactivity
was quantitatedby liquid scintillation counting. Thedata demonstrated that
95% of the CPM appligd each lane, as indicated by the CPM in each
lane ofthe untransfermd; stained gel, was bound tothe nitrocellulose sheet
adjacent to the gel. Only background levels of radioactivity were detected
on the more distal nitrocellulose sheet. Based on these data, we believe that
we are quantitatively transferring myosinII heavy chains without loss ofthe
light chains.
MLC2o Phosphoryladon
Macrophages (3 x 106 cells) were electroinjected with MK-, trypsin-
treated BSA, MK-Ab, or CAbat a concentration of2 .5 mg/ml at 700 V/cm
and 15 KR The cells were collected, resuspended, and incubated in 0.5 ml
of phosphate-free Gey's buffer containing 0.5 MCi of 32p for 60 min at
37°C. Cells injected with MK-Ab and CAb were then treated with 1 14M
okadaic acid for 10 min. At 70 min, all cells were extracted by freeze/thaw-
ing andthe myosin wasimmunoprecipitatedusing antibodies toplatelet my-
osinII aspreviously described (25). The immunoprecipitated proteins were
separatedby SDS-PAGE (5-20% acrylamide separatinggel) and transferred
to nitrocellulose as described above. The nitrocellulose sheets were then
processed as Western blots and the band representing the myosin II heavy
chain in each lane was quantitated densitometrically as described in the
previous paragraph. The area defined by the densitometer tracing was taken
as a representation ofthe myosinII heavy chain in each immunoprecipitate.
The blot was exposed to an X-ray film and the region representing MLC2o
ineachlanewas excised and theradioactivity quantitated by liquid scintilla-
tion counting. The MLC2o CPM were divided by the area representing the
heavy chains from the densitometer tracing tocorrect for the amountof my-
osin II in each imlnunoprecipitate. The CPM/unit area for MKAb and
MK- were then divided by the CPM/unit area for CAb and BSA, respec-
tively, to determine the relative change in MLC2o phosphorylation:
Results
A modification of the voltage discharge technique, called
electroinjection (7, 32, 35), was used to introduce proteins
into macrophages. Experiments that were performed to
characterize the effect of electroinjecting macrophages are
described in Fig. 1. Fig. 1 A illustrates the effect of field
strength on macrophage viability assessed by two different
methods. Viability, as judged by trypan blue exclusion, re-
mained high over all voltages tested. However, chemotaxis
diminished at field strengths >900 V/cm. The relationship
between protein loading and fieldstrength was also assessed.
The data in Fig. 1 B demonstrate that protein incorporation
increased as the field strength increased. Flow cytometry
was also performed on cells loaded with FITC-BSA at 700
V/cm (Fig. 1 C). These experiments demonstrated a single
population of labeled cells that contained more fluorescence
than cells merely incubated with the FITC-BSA. Since
Rat alveolar macrophages either incubated or electroinjected in the
presence of 2 .5 mg/ml fluorescein-labeled BSA were analyzed by
flow cytometry as described in Materials and Methods. The spectra
illustratethe numberofcells ineach fluorescencechannel that were
either only incubated with (0 V/cm) or electroinjected at 700 V/cm
with fluorescein-labeled BSA. Native macrophage fluorescence
was subtracted from both spectra. The x-axis is alog scale and these
spectra are representative of three separate experiments.
279significant amounts of protein could be loaded relatively uni-
formly into cells and the number of cells that migrated re-
mained high up to900 V/cm, we used 700V/cm and 15 AF
as our standard conditions for electroinjecting macrophages
(see ref. 32 for amore complete characterization of the elec-
troinjection technique) .
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Figure 3. Effect ofMK-Ab (o) and C-Ab (e) on macrophage motil-
ity as a function of chemoattractant concentration . Macrophages
were electroinjected at 700 V/cm in the presence of 2.5 mg/ml of
C-Ab orMK-Ab . The chemotaxis assay was performed using vary-
ing concentrations of endotoxin-activated rat serum . Percentage
migration was calculated based on the number of cells electroin-
jected with C-Ab that migrated at the optimum concentration of
endotoxin-activated rat serum as 100% . There was no statistically
significant difference in the migration of untreated cells and cells
electroinjected with C-Ab . However, inhibition of migration due to
MK-Ab incorporation was significantly decreased (p<0.001) as de-
termined by analysis of variance (9) (n = 3) .
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Figure 2 . Interaction of MK-
Ab with macrophage MLCK .
(left panel) Macrophage
MLCK was concentrated by
ammonium sulfate fraction-
ation (Materials and Meth-
ods) . The effect ofpreincubat-
ing aliquots of this MLCK
fraction with C-Ab or MK-Ab
on MLCZo phosphorylation
was then determined as de-
scribed inMaterialsand Meth-
ods . The data demonstrate in-
hibition of 'ZP incorporation
by MK-Ab . (right panel)
Western blot analysis of mac-
rophage (M) and chick em-
bryo fibroblasts (CF) pro-
teins . Approximately 100 ug
of macrophage and fibroblasts
proteinwasseparated by SDS-
PAGE, transferred to nitrocel-
lulose, and probed with MK-
Ab as described in Materials
and Methods. The most in-
tensely staining bands in the
macrophage and fibroblast ex-
tracts had an M, = 130,000
and comigrated with purified
chicken gizzard MLCK .
After optimization of the electroinjection conditions, we
assessed the effects of electroinjecting MK-Ab on macro-
phage motility. MKAb are affinity-purified rabbit antibodies
to turkey gizzard smooth muscle MLCK that have been
characterized extensively (11-13) . They are monospecific an-
tibodies that exhibit wide cross-reactivity withMLCK found
in smooth muscle and nonmuscle cells . On a Western blot
analysis, MK-Abs bind to a macrophage protein withM =
130,000 (Fig . 2) . In addition, these antibodies inhibit the
catalytic activity of smooth muscle and non-muscle MLCK
(11, 13), including macrophage MLCK (Fig . 2) .
The effect of electroinjectingMKAb on macrophagemo-
tility is shown in Fig . 3. Macrophages electroinjected with
control antibodies display a characteristic chemotactic re-
sponse, including high dose inhibition ofmigration (15), that
is nearly identical to the response of untreated cells . In con-
trast, the incorporation of MK-Ab resulted in decreased
migration at all concentrations of chemoattractant, and
caused a44 t 6% decrease in the number of cells migrating
at the optimal concentration of the chemoattractant .
To determine whether the degree of inhibition was depen-
dent on the amountofMK-Ab introduced into the cells, mac-
rophages were loaded with different amounts of antibody by
electroinjection at different field strengths . Field strength,
rather than protein concentration, was varied in these experi-
ments for two reasons . First, there is a direct relationship be-
tween field strength and incorporation (Fig . 1 B) . Second,
MKAbs precipitate when the concentration exceeds 2 .5
mg/ml . Chemotaxis assays, performed at the optimal con-
centration of chemoattractant, demonstrated that decreased
numbers of cells loaded with C-Ab migrated as the field
strength was increased above 700 V/cm (Fig. 4) . This was
expected fromthe data in Fig . 1 A . However, MKAb-loaded
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C-AbFigure4 . Effect ofMK-Ab (o) and C-Ab (9) on macrophage motil-
ity as a function of increasing antibody incorporation . Macro-
phages were electroinjected at varying field strengths in the pres-
ence of 2.5 mg/ml of C-Ab or MK-Ab . Chemotaxis was performed
at the optimal concentration of endotoxin-activated rat serum as
defined in Fig . 2 . Percent migration was calculated based on the
number of cells incubated with C-Ab but not electroinjected (0
V/cm) that migrated as 100% . The data represent the means oftwo
experiments at 500 and 900 V/cm . The data at 0 and at 700 V/cm
(n = 5) include the mean values ofthe cells migrating at the optimal
concentration of endotoxin-activated rat serum from the three ex-
periments in Fig. 3 . Data from C-Ab- and MK-Ab-treated cells
were significant individually withp values< 0.001 when comparing
field strength effects and MK-Ab effects, separately, on migration
as determined by analysis of variance (9) .
macrophages exhibited additional inhibition of migration at
each field strength (Fig . 4) . That is, fewer macrophages
loaded with MK-Ab migrated at each field strength as com-
pared with cells electroinjected with C-Ab.
We next investigated the effect of increasing intracellular
MLCK activity on cell motility by electroinjecting MK-
into macrophages. MLCK is unique in that it only catalyzes
the phosphorylation of MLC 2o (2) . This is in contrast to
most protein kinases, which phosphorylate multiple sub-
strates (18) . MK- , produced by digesting purified chicken
gizzard MLCK with trypsin (21), is an unregulated (i.e .,
Cal+/calmodulin-independent) form of the enzyme that re-
tains its specificity for MLC2o. We verified this by perform-
ing in vitro phosphorylation assays on extracts prepared
from electroinjected cells . These experiments demonstrated
that MK- retains its catalytic activity after electroinjection
and that it only phosphorylates MLC2o (data not shown) .
When electroinjected into cells (Fig . 5), the number of cells
that migrated decreased as a function of the MK- concen-
tration in the electroinjection buffer. Since protein incorpo-
ration is directly related to the protein concentration in the
electroinjection buffer (32), these data demonstrate an in-
verse relationship between intracellular MLCK activity and
cell motility .
Finally, we investigated the effects ofelectroinjecting mac-
rophages with MKAb orMK- on MLC 2o phosphorylation
and the distribution of myosin II (Table I) . MLC2o phos-
phorylation was determined by immunoprecipitating myosin
II from electroinjected cells . Cells electroinjected with C-Ab
or MKAb were treated with a phosphoprotein phosphatase
inhibitor, okadaic acid, that has been shown to increase
MLC 2o phosphorylation in macrophages (33) . It was neces-
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Figure 5. Effect of MK- incorporation on macrophage motility .
Macrophages were electroinjected at 700 V/cm in the presence of
equivalent concentrations of trypsin-treated BSA (control cells) or
MK- . The protein concentration in the electroinjection buffer was
varied as shown because there is a direct relationship between the
protein concentration in the electroinjection buffer and incorpora-
tion into the cells (32) . Chemotaxis was then performed using the
optimal concentration of endotoxin-activated rat serum as defined
in Fig . 2 . Migration of cells electroinjected with MK- are reported
as the percent of control cell migration at each protein concentra-
tion . The migration of control cells (i.e ., cells electroinjected with
trypsinized BSA) was virtually identical to the migration of cells
incubated, but not electroinjected, with BSA . Each data point
represents one experiment .
sary to treat these cells with okadaic acid, because the level
of MLC2o phosphorylation in untreated cells was so low
(see lane marked BSA in Fig. 6) that the assay was not sensi-
tive enough to demonstrate a decrease following electroin-
jection ofMKAb . Treating the cells with 1 p.M okadaic acid
raised the level of MLC2o phosphorylation sufficiently to
permit detection of the effect of MKAb on MLC 2o phos-
phorylation . Cells electroinjected with MK- or BSA did
not require such manipulation . The data in Fig. 6 clearly
demonstrate a decrease in MLC2o phosphorylation in cells
electroinjected with MKAb compared to cells electroin-
jected with C-Ab, albeit under somewhat different conditions
than used in Figs . 3 and 4 and in Table 11 . They also demon-
strate an increase in MLC2o phosphorylation in cells in-
Figure 6. MLC2o phosphory-
lation in electroinjected mac-
rophages . Macrophages (3 x
106 cells) were electroin-
jected with MK- , trypsin-
treated BSA, MK-Ab, or C-Ab
at concentrations of 2.5
mg/ml at 700 V/cm . Myosin II
was immunoprecipitated from
cells incubated with '2P as
described in Materials and
Methods . The immunoprecip-
itated proteins were separated
by SDS-PAGE, transferred to nitrocellulose, and exposed to an
X-ray film . A photograph of the X-ray film from a representative
experiment out ofthree that were performed is shown in this figure .
The numbers 204 and 20 refer to the molecular weights (x10- ') of
myosin II heavy chain and MLC2o .
281Table I. Relative Change in MLC2o Phosphorylation
MLC2o phosphorylation
(Fold change compared to control)
MK-Ab
￿
0.68 t 0.15
MK- ￿1 .77 t 0.23
Changes in MLC2o phosphorylation in macrophages electroinjected with MK-
Ab or MK- were compared to their respective controls (n = 3). Relative
MLC2o phosphorylation wasquantitated as described in Materials and Meth-
ods. Note that cells electroinjected with MK-Ab or C-Ab were treated with
1 uM okadaic acid, whereas cells electroinjected with MK- or trypsin-treated
BSA were not treated with okadaic acid.
jected with MK- compared to cells electroinjected with
trypsinized BSA. The changes in MLC2o phosphorylation
were more quantitatively compared (Table I) by normalizing
the data as described in Materials and Methods. The nor-
malized data demonstrate that MLC2o phosphorylation is
decreased in cells injected with MK-Ab and increased in
cells injected with MK- compared to their respective con-
trols (Table I).
The distribution of myosin II in electroinjected cells was
also quantitated because MLC2o phosphorylation affects fila-
ment formation by myosin II (10, 27). Electroinjected cells
were extracted with Triton and the myosin II in the Triton-
soluble (cytoplasmic) and Triton-insoluble (cytoskeletal)
fractions was quantitated by Western blotting, using anti-
bodies to platelet myosin II, in order to identify unequiv-
ocally the myosin II heavy chains in each fraction and to in-
crease the sensitivity of the assay. As shown in Table II,
electroinjection of MKAb did not affect the distribution of
myosin II. In contrast, there is almost a twofold increase in
the amount of myosin II associated with the cytoskeleton in
cells electroinjected with MK- compared to cells electro-
injected with BSA, C-Ab, or MK-Ab.
Discussion
We have investigated the importance of MLCzo phosphory-
lation in mediating cell motility by using antibodies to
MLCKand a constitutively active form ofMLCKto vary in-
tracellular MLCK activity. These proteins were electroin-
jected into living cells. Electroinjection is a modification of
the voltage discharge technique that has previously been
used for transfecting (34), permanently permeabilizing, or
fusing cells (35). Electroinjection differs from these earlier
applications in that it uses milder conditions and is designed
to maintain high levels of cell viability. Since electroinjec-
tion has not been used extensively, we performed a number
ofexperiments to characterize the effectof subjecting macro-
phages to electricaldischarges. Data from these experiments
demonstrate thatviability, asjudged by trypan blue exclusion
and by a physiological assay (Fig. 1), remains high when
electroinjection is performed under carefully defined condi-
tions. It is also possible to electroinject large amounts ofpro-
tein into cells. Based on an average diameter of 16 Am, the
calculated concentration of rhodamine-labeled BSA in cells
shocked at 700 V/cm, 15 AF is 2 AM . However, all of this
protein may not be in the cytoplasm (32) . Finally, flow
cytometry of cells electroinjected with fluoresceinated BSA
demonstrated relatively uniform labeling of all cells.
Both experimental probes that were electroinjected into
macrophages are extremely specific. MK-Abs are affinity-
purified antibodies that have been shown to be monospecific
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Table IL Cellular Distribution ofMyosin in Macrophages
following Electroinjection of Various Proteins
Macrophages were electroinjected at 700 V/cm, 15 pF in the presence of
2.5 mg/ml control antibodies (C-Ab), 2.5 mg/ml antibodies to MLCK (MK-
Ab), 5.8 mg/ml trypsinized BSA or 5.8 mg/ml unregulated MLCK (MK-).
Myosin distribution was determined by treating cells with Triton X-100 as
described in Materials and Methods. The number oftrials in each experimental
group is shown in brackets and the data represent the mean t SE.
for MLCK (Fig. 2 and refs. 11-13), whereas MK- main-
tains the specificity of the parent enzyme for MLC2o (21) .
Data from experiments using these proteins provide compel-
ling evidence in support of the hypothesis that MLCKactiv-
ity and MLC2o phosphorylation are important elements in
mediating mammalian cell motility. Two major conclusions
can be drawn from these results. First, changes in MLCK
activity inhibit cell motility. Second, the data indicate that
MLC2o phosphorylation must be maintained within narrow
limits to support motility. Apparently, an increase or a de-
crease in MLC2o phosphorylation is sufficient to inhibit
motility.
The explanation for these observations is complex. Since
MKAbs decreases MLC2o phosphorylation and MK- in-
creases it (Fig. 6 and TableI), these proteins probably inhibit
motility by affecting ATP hydrolysis and myosin II polymer-
ization/depolymerization in different ways. Cell locomotion
requires the simultaneous extension of the leading edge and
retraction ofthe trailing edge, processes that are thought to
depend on myosin I (17) and/or actin polymerization (6, 29)
and a MLCK-catalyzed, myosin II-mediated contractile
event (6, 8, 17, 20, 26), respectively. This, in turn, suggests
that motile cells require exquisitely sensitive regulatory
mechanisms to determine the spatial distribution of these
reactions. MK-Abs appear to prevent motility by inhibiting
ATP hydrolysis by actin and myosin II, thereby preventing
tail retraction, whereas MK- may inhibit motility by
stimulating ATP hydrolysis in spatially inappropriate regions
of the cell. Thus, MK-Ab and MK- may affect motility by
disrupting the spatial and temporal integration of ATP hy-
drolysis by actin and myosin II in opposite ways.
Simultaneously, changes in MLC2o phosphorylation
couldalso have a profound effect on myosin filaments andthe
cytoskeleton. Motile cells continually change shape as they
migrate from one point to another and the continual reor-
ganization of the cytoskeleton is essential forcell motility (5,
28). It is now well-established that MLC2o phosphorylation
regulates both ATP hydrolysis (2, 30, 31) and the ability of
mammalian smooth muscle and nonmuscle myosin II to
form filaments (10, 27). Unphosphorylated myosin II resides
in a folded, 10S conformation, whilephosphorylated myosin
II has a sedimentation coefficient of6S and an extended con-
formation. Most importantly, only phosphorylated 6S myo-
sin II can form filaments (10, 27).
Therefore, we investigated the effect of MK-Ab and MK-
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Electroinjected
protein
Myosin
% Cytoplasmic
(Triton soluble)
distribution
% Cytoskeletal
(Triton insoluble)
C-Ab (4) 72.3 f 4.9 27.7 t 4.9
MK-Ab (4) 69.6 f 4.8 30.3 t 4.8
BSA (3) 71 .6 t 5.1 28.4 t 5.1
MK- (3) 45 .5 f 9.7 54.5 t 9.7on the intracellular distribution of myosin II. MKAb re-
duced MLC2o phosphorylation (Fig. 6 and Table I) but had
no effect on myosin II distribution (Table II) . MK-, mean-
while, increased both MLC2o phosphorylation (Fig. 6 and
Table I) and the amount of myosin II associated with the cyto-
skeleton (Table II). These data suggest that MKAbs inhibit
motility by inhibiting MLCK activity and decreasing MLC2o
phosphorylation rather than preventing the polymerization
of myosin II into filaments. In contrast, the introduction of
MK- appears to result in an increase in myosin II filaments,
secondary to an increase in MLC2o phosphorylation. Con-
sequently, MK- appears to inhibit motility by stimulating
ATP hydrolysis in spatially inappropriate locations and/or by
decreasing the fluidity of the cytoskeleton by stimulating the
polymerization of myosin II into filaments.
What, then, can be said about the relative importance of
myosin I and myosin II in mammalian cell motility? Al-
though myosin I has not been identified in macrophages, we
cannot exclude the possible existence of myosin I in these
cells. However, a myosin I light chain kinase has not been
described in vertebrate tissues and turkey gizzard MLCK
does not phosphorylate myosin I purified from the chicken
brush border (J. Collins, Eastern Virginia Medical School,
personal communication). These data and the specificity of
MKAb (11-13) and MK- (21) argue against the possibility
that they are affecting myosin I should it exist in macro-
phages. Consequently, our data establish a central role for
myosin II in mammalian cell motility by demonstrating that
an increase or a decrease in MLCK activity and in MLC2o
phosphorylation adversely affect macrophage motility.
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